Non-Invasive Brain Stimulation for Traumatic Brain Injury
(SMART Trial)
Trial Summary
What is the purpose of this trial?
This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
What data supports the effectiveness of the treatment COGED, External non-invasive stimulation, for traumatic brain injury?
Is non-invasive brain stimulation safe for humans?
Non-invasive brain stimulation, including techniques like transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), has been studied for safety in humans. While more research is needed, current studies suggest it is generally safe, with no major safety concerns reported in trials for traumatic brain injury and other conditions.678910
How is the treatment COGED different from other treatments for traumatic brain injury?
COGED is unique because it uses non-invasive brain stimulation, which means it stimulates the brain from outside the body without surgery. This approach aims to enhance neuroplasticity (the brain's ability to reorganize itself) and improve recovery after a traumatic brain injury, offering a novel way to potentially aid recovery compared to traditional methods.24111213
Research Team
David Darrow, MD MPH
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for adults over 18 who've had a mild to moderate traumatic brain injury (TBI) and can perform computerized tests. They must understand the consent process and commit to all appointments. It's not for those with severe TBI, scalp wounds, pacemakers/defibrillators, non-English speakers, or visual issues affecting computer use.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcutaneous alternating current stimulation (tACS) or sham stimulation once weekly for six weeks to improve cognitive function and decision-making after traumatic brain injury
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- COGED
- External non-invasive stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
United States Department of Defense
Collaborator
Uniformed Services University of the Health Sciences
Collaborator